- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01958086
Visuomotor Prosthetic for Paralysis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of the proposed research is to obtain scientific knowledge of visuomotor transformations in posterior parietal cortex (PPC) and primary motor cortex (M1) from tetraplegic subjects in a clinical trial to advance the development of neural prosthetics. We have shown in clinical trials conducted over the past 6 years that PPC can control neural prosthetics for assisting tetraplegic subjects. Other groups have concentrated on M1 and likewise find control for neural prosthetics. In our studies of PPC we have found that besides trajectory signals to move robotic limbs or control computer cursors, there are a plethora of visuomotor signals that represent intended movements of most of the body, movement goals, cognitive strategies, and even memory signals. Our central hypothesis is that PPC and M1 will encode visuomotor parameters in both similar and different ways, and that algorithms can be developed to leverage those signals from the two areas that are complimentary to improve prosthetic range and performance. Implants will be made in both M1 and PPC, enabling simultaneous recording in the same subjects, elevating concerns of comparing data from different labs collected in different individuals with different implants and different tasks.
This central hypothesis will be tested in two broad aims, for which we have substantial preliminary data. Aim 1 will examine the control of the body by the two areas. It is hypothesized that M1 will demonstrate strong specificity for the contralateral limb (implants will be made in the hand knob) whereas PPC will code movements for most of the body and on both contra and ipsilateral sides by leveraging its partially mixed encoding of parameters (subaim 1a). Whereas M1 is hypothesized to code spatial variables exclusively during attempted or imagined actions, it is hypothesized that PPC also encodes cognitive spatial variables in task appropriate reference frames (subaim 1b). In subaim 1c we will examine how multiple body parts are combined in movement representations, hypothesizing that M1 and PPC will employ a diverse set of mechanisms including linear summation, non-linear combinations, and movement suppression expressed in different ways as a function of brain area and the specific movement set.
Aim 2 will examine the temporal aspects of encoding in the two areas. In subaim 2a we will test the hypothesis that the neural dynamics during sustained periods of movement are largely unchanging in both areas. In subaim 2b we hypothesize that, during sequential movements, M1 codes only the ongoing movement whereas PPC codes both the current and subsequent movements. Finally, in subaim 2c we will examine the coding of movement speed, with the hypothesis that there are separate subspaces in both M1 and PPC for direction and speed of movement.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ausaf Bari, MD, PhD
- Phone Number: 310-825-5111
- Email: ABari@mednet.ucla.edu
Study Contact Backup
- Name: Emily Rosario, PhD
- Phone Number: 3036 909.596.7733
- Email: ERosario@casacolina.org
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- Recruiting
- University of California Los Angeles
-
Contact:
- Ausaf Bari
-
Pasadena, California, United States, 91125
- Recruiting
- California Institute of Technology
-
Pomona, California, United States, 91769
- Recruiting
- Casa Colina Centers for Rehabilitation
-
Contact:
- Emily Rosario, PhD
- Phone Number: 3036 909-596-7733
- Email: erosario@casacolina.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pathology resulting in paralysis
- Age 22-65 years
- Able to provide informed consent
- Understand and comply with instructions, if necessary, with the aid of a translator
- Able to communicate via speech
- Surgical clearance
- Life expectancy greater than 12 months
- Live within 60 miles of study location and willing to travel up to 5 days per week
- A regular caregiver to monitor the surgical site
- Psychosocial support system
- Stable ventilator status
Exclusion Criteria:
- Intellectual impairment
- Psychotic illness or chronic psychiatric disorder, including major depression if untreated
- Poor visual acuity
- Pregnancy
- Active infection or unexplained fever
- Scalp lesions or skin breakdown
- HIV or AIDS infection
- Active cancer or chemotherapy
- Medically uncontrolled diabetes
- Autonomic dysreflexia
- History of seizure
- Implanted hydrocephalus shunt
- History of supratentorial brain injury or neurosurgery
- Medical conditions contraindicating surgery and chronic implantation of a medical device
- Unable to undergo MRI or anticipated need for MRI during study
- Nursing an infant or unwilling to bottle-feed infant
- Chronic oral or intravenous use of steroids or immunosuppressive therapy
- Suicidal ideation
- Drug or alcohol dependence
- Planning to become pregnant, or unwilling to use adequate birth control
- Implanted Cardiac Defibrillator, Pacemaker, vagal nerve stimulator, or spinal cord stimulator.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Neural Communication System
The Neural Communication System consists of two Neuroport Multi-Port Arrays, which are descried in detail in the intervention description.
One Neuroport Multi-Port Array is inserted into the posterior parietal cortex, an area of the brain used in reach planning.
The second Neuroport Multi-Port Array is inserted into the motor cortex, which is primarily responsible for controlling movement.
The arrays are inserted and the percutaneous pedestal is attached to the skull during a surgical procedure.
Following surgical recovery the subject will participate in study sessions 3-5 times per week in which they will learn to use thought to control a simple computer environment or a tablet computer.
|
NeuroPort Arrays allow for the local recording of cerebral cortex.
The Neural Communication system is primarily composed of two NeuroPort Arrays.
The two arrays of one MultiPort device will be placed in the primary motor cortex for recording (Platinum-tipped electrodes); and the two arrays of the additional MultiPort device be placed in the superior parietal lobule for recording (Platinum-tipped electrodes).
Each MultiPort device consists of two arrays, each with 100 electrodes in a 10 x 10 configuration, with dimensions 4 mm x 4 mm x 1.5 mm (W x H x D) or 4 mm x 4 mm x 1.0 mm, and a titanium percutaneous connector, 19 mm diameter at the base.
Each MultiPort can have a total of 128 active channels (capable of transmitting neural signals to the percutaneous connector) across the two arrays.
In our design, we will split active channels evenly between the two arrays resulting in 64 active channels per array.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subject control of a tablet computer
Time Frame: Six years after array implantation
|
Assessments will be compared with chance and previous reports of BMI efficacy using control signals derived from primary motor cortex.
Computer-interface competency examination that measures the ability of the subject to control various aspects of the tablet user interface.
Additionally we will measure the Quality of Life Inventory (QOLI) at regular intervals over the duration of the study.
Changes in performance over time.
|
Six years after array implantation
|
Absence of infection or irritation
Time Frame: Six years after array implantation
|
The Serious Adverse event (SAE) rate will be calculated as the number of SAEs per implant-days. The SAE rate will be continuously compared to the 1% threshold level. CT scan; inspection of patient's scalp for evidence of reddening or discharge; review of new symptoms including possible fever, headache, visual or auditory changes, or change in mood or behavior; serial neurologic exams. The condition of the area will be compared with its condition on previous visits. History will be obtained regarding new symptoms. Neurologic exam will be compared to baseline neurologic exam |
Six years after array implantation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Richard A Andersen, PhD, California Institute of Technology
- Principal Investigator: Emily Rosario, PhD, Casa Colina Hospital and Centers for Healthcare
- Principal Investigator: Ausaf Bari, MD, PhD, University of California, Los Angeles
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- G120287
- 13-000576 (Other Identifier: UCLA IRB application number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quadriplegia
-
Virginia Commonwealth UniversityMedical University of South Carolina; Eunice Kennedy Shriver National Institute...CompletedQuadriplegia/TetraplegiaUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de Recherche en Informatique et en Automatique; Centre Bouffard... and other collaboratorsCompleted
-
Swiss Paraplegic Centre NottwilCompleted
-
VA Palo Alto Health Care SystemONWARD Medical, Inc.Not yet recruitingTetraplegiaUnited States
-
Neuracle Medical Technology(Shanghai) Co.,Ltd.Beijing Tiantan Hospital; Chinese PLA General Hospital; Xuanwu Hospital, BeijingNot yet recruiting
-
Jonathan Miller, MDRecruiting
-
Centre Bouffard Vercelli - USSAPInstitut National de Recherche en Informatique et en Automatique; NEURINNOVCompleted
-
Virginia Commonwealth UniversityWithdrawn
-
Centre d'Investigation Clinique et Technologique...University of VersaillesUnknown
-
Richard A. Andersen, PhDUniversity of Southern California; Rancho Los Amigos National Rehabilitation... and other collaboratorsRecruiting
Clinical Trials on Neural Communication System
-
Leigh R. Hochberg, MD, PhD.National Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingAmyotrophic Lateral Sclerosis | Muscular Dystrophies | Spinal Cord Injuries | Tetraplegia | Dysarthria | Brain Stem Infarctions | Locked-in Syndrome | AnarthriaUnited States
-
Leigh R. Hochberg, MD, PhD.National Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingAmyotrophic Lateral Sclerosis | Muscular Dystrophies | Spinal Cord Injuries | Tetraplegia | Dysarthria | Brain Stem Infarctions | Locked in Syndrome | AnarthriaUnited States
-
Chad BoutonRecruitingSpinal Cord Injuries | Spinal Cord Injury CervicalUnited States
-
Josue Fernandez CarneroUniversidad Autonoma de MadridCompleted
-
Taipei Veterans General Hospital, TaiwanUnknownDevelopment and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS.ALS (Amyotrophic Lateral Sclerosis)Taiwan
-
Universidad Rey Juan CarlosUnknown
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanRecruiting
-
University of Massachusetts, WorcesterBrown UniversityCompletedCommunication | Ventilation Therapy; ComplicationsUnited States
-
Riphah International UniversityCompletedCervical RadiculopathyPakistan